Joanne advises clients around the world in the food, drug, and biotechnology industries on issues ranging from prescription drug advertising to state licensing requirements for wholesale distribution. In particular, Joanne counsels clients on the business impact of new US federal and state actions that affect regulated products, such as drugs, foods, and medical devices.
Joanne is experienced in US federal drug regulations, including pre-market and post-market requirements, and restrictions on advertising and sampling. Joanne also has counseled clients on state regulation of prescription drug distribution and licensing requirements. She is well versed in advising clients on the regulatory considerations for marketing controlled substances, track-and-trace systems for prescription drugs, and the food safety and labeling requirements for human and animal food. Joanne also has counseled both pharmacies and practitioners on drug compounding regulatory matters. In addition, she has worked with manufacturers and retailers to determine the regulatory status of certain medical devices, laboratory tests, and mobile medical applications.
Articles in the National Law Review database by Joanne S. Hawana